| For: | Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol 2012; 18(3): 197-204 [PMID: 22294822 DOI: 10.3748/wjg.v18.i3.197] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i3/197.htm |
| Number | Citing Articles |
| 1 |
Kiyoshi Maeda, Hisashi Nagahara, Masatsune Shibutani, Hiroshi Otani, Katsunobu Sakurai, Takahiro Toyokawa, Hiroaki Tanaka, Naoshi Kubo, Kazuya Muguruma, Noriko Kamata, Hirokazu Yamagami, Kosei Hirakawa. A preoperative low nutritional prognostic index correlates with the incidence of incisional surgical site infections after bowel resection in patients with Crohn’s disease. Surgery Today 2015; 45(11) doi: 10.1007/s00595-014-1044-8
|
| 2 |
Dario Sorrentino, Sandy Fogel, Johan Van den Bogaerde. Surgery for Crohn’s disease and anti-TNF agents: the changing scenario. Expert Review of Gastroenterology & Hepatology 2013; 7(8) doi: 10.1586/17474124.2013.842895
|
| 3 |
Andrei Dan, Marylise Boutros, Hacene Nedjar, Uri Kopylov, Waqqas Afif, Maria Abou Khalil, Elham Rahme. Cost of Ulcerative Colitis in Quebec, Canada. Inflammatory Bowel Diseases 2017; 23(8) doi: 10.1097/MIB.0000000000001147
|
| 4 |
Cheryl Lau, Marla Dubinsky, Gil Melmed, Eric Vasiliauskas, Dror Berel, Dermot McGovern, Andrew Ippoliti, David Shih, Stephan Targan, Phillip Fleshner. The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery. Annals of Surgery 2015; 261(3) doi: 10.1097/SLA.0000000000000757
|
| 5 |
Anita Afzali, Christopher J. Park, Kehao Zhu, Jie Kate Hu, Prachi Sharma, Mika N. Sinanan, Scott D. Lee. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(8) doi: 10.1097/MIB.0000000000000780
|
| 6 |
N. Horesh, M. R. Freund, Z. Garoufalia, R. Gefen, D. Zhang, T. Smith, S. H. Emile, S. D. Wexner. Biological therapy prior to repeat ileocolic resection in Crohn’s disease can reduce the postoperative complication rate. Techniques in Coloproctology 2023; 27(4) doi: 10.1007/s10151-022-02702-0
|
| 7 |
Ankita Wal, Pranay Wal, Deependra Singh, Manju Rawat Singh. Nanocarriers Based Colon Targeting. 2025; doi: 10.1016/B978-0-443-24806-1.00024-8
|
| 8 |
Kun Guo, Jianan Ren, Guanwei Li, Qiongyuan Hu, Xiuwen Wu, Zhiwei Wang, Gefei Wang, Guosheng Gu, Huajian Ren, Zhiwu Hong, Jieshou Li. Risk factors of surgical site infections in patients with Crohn’s disease complicated with gastrointestinal fistula. International Journal of Colorectal Disease 2017; 32(5) doi: 10.1007/s00384-017-2751-6
|
| 9 |
Kim C. Lu, Steven R. Hunt. Surgical Management of Crohn's Disease. Surgical Clinics of North America 2013; 93(1) doi: 10.1016/j.suc.2012.09.002
|
| 10 |
Bradley Davis, David E. Rivadeneira. Complications of Colorectal Anastomoses. Surgical Clinics of North America 2013; 93(1) doi: 10.1016/j.suc.2012.09.014
|
| 11 |
Xiaoping Luo, Zhilun Yu, Chao Deng, Jingjing Zhang, Gaiyan Ren, Aning Sun, Sridhar Mani, Zhengtao Wang, Wei Dou. Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12562-6
|
| 12 |
Takayuki Yamamoto, Manabu Shiraki. Risk Assessment of Postoperative Complications in Crohn’s Disease. Diseases of the Colon & Rectum 2013; 56(3) doi: 10.1097/DCR.0b013e31827cd045
|
| 13 |
Rogério SAAD HOSSNE, Ligia Yukie SASSAKI, Julio Pinheiro BAIMA, José Donizeti de MEIRA JÚNIOR, Luana Moraes CAMPOS. ANALYSIS OF RISK FACTORS AND POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH CROHN’S DISEASE. Arquivos de Gastroenterologia 2018; 55(3) doi: 10.1590/s0004-2803.201800000-63
|
| 14 |
Ingrid Jouvin, Jérémie H Lefevre, Ben Creavin, Sophie Pitel, Najim Chafai, Emmanuel Tiret, Laurent Beaugerie, Yann Parc. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn’s Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients. Inflammatory Bowel Diseases 2018; 24(2) doi: 10.1093/ibd/izx036
|
| 15 |
Kiyoshi Maeda, Hisashi Nagahara, Masatsune Shibutani, Tatsunari Fukuoka, Yasuhito Iseki, Shinji Matsutani, Takahiro Toyokawa, Hiroaki Tanaka, Kazuya Muguruma, Hirokazu Yamagami, Kosei Hirakawa, Masaichi Ohira. Preoperative Neutrophil-to-Lymphocyte Ratio Is Correlated with Severe Postoperative Complications After Emergency Surgery for Ulcerative Colitis. International Surgery 2019; 104(11-12) doi: 10.9738/INTSURG-D-16-00216.1
|
| 16 |
C.-T. Germer, C. Isbert. Operative Therapie chronisch-entzündlicher Darmerkrankungen. Der Internist 2014; 55(8) doi: 10.1007/s00108-013-3444-z
|
| 17 |
Xiaoqi Huang, Zhiwei Chen, Minyao Li, Yaomin Zhang, Shijie Xu, Haiyang Huang, Xiaoli Wu, Xuebao Zheng. Herbal pair Huangqin-Baishao: mechanisms underlying inflammatory bowel disease by combined system pharmacology and cell experiment approach. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03068-2
|
| 18 |
Weiming Zhu, Zhen Guo, Lugen Zuo, Jianfeng Gong, Yi Li, Lili Gu, Lei Cao, Ning Li, Jieshou Li. CONSORT. Medicine 2015; 94(29) doi: 10.1097/MD.0000000000001175
|
| 19 |
Jennifer S. Davids, Justin A. Maykel. The ASCRS Textbook of Colon and Rectal Surgery. 2016; doi: 10.1007/978-3-319-25970-3_6
|
| 20 |
Abel Botelho Quaresma, Fernanda da Silva Barbosa Baraúna, Fábio Vieira Teixeira, Rogério Saad-Hossne, Paulo Gustavo Kotze. Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review. Journal of Clinical Medicine 2021; 10(4) doi: 10.3390/jcm10040710
|
| 21 |
Ryan Nelson, Chuanhong Liao, Alessandro Fichera, David T. Rubin, Joel Pekow. Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(1) doi: 10.1097/01.MIB.0000437497.07181.05
|
| 22 |
Hang Hock Shim, Christopher Ma, Paulo G Kotze, Cynthia H Seow, Heba Al-Farhan, Ahmed K Al-Darmaki, Jack X Q Pang, Richard N Fedorak, Shane M Devlin, Levinus A Dieleman, Gilaad G Kaplan, Kerri L Novak, Karen I Kroeker, Brendan P Halloran, Remo Panaccione. Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study. Journal of the Canadian Association of Gastroenterology 2018; 1(3) doi: 10.1093/jcag/gwy013
|
| 23 |
Mark A. Samaan, Preet Bagi, Niels Vande Casteele, Geert R. D’Haens, Barrett G. Levesque. An Update on Anti-TNF Agents in Ulcerative Colitis. Gastroenterology Clinics of North America 2014; 43(3) doi: 10.1016/j.gtc.2014.05.006
|
| 24 |
Neha Deshpande, Gabrielle Berger. The Perioperative Medicine Consult Handbook. 2020; doi: 10.1007/978-3-030-19704-9_18
|
| 25 |
Carlo Selmi, Angela Ceribelli, Stanley M Naguwa, Luca Cantarini, Yehuda Shoenfeld. Safety issues and concerns of new immunomodulators in rheumatology. Expert Opinion on Drug Safety 2015; 14(3) doi: 10.1517/14740338.2015.993605
|
| 26 |
Ron G. Landmann, Todd D. Francone. The ASCRS Textbook of Colon and Rectal Surgery. 2022; doi: 10.1007/978-3-030-66049-9_6
|
| 27 |
Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Miguel Regueiro, Ahmed E Sherif, Peter Neary, Francesco Pata, Mark Silverberg, Stefan Clermont, Sami A Chadi, Sameh Emile, Nicolas Buchs, Monica Millan, Ana Minaya-Bravo, Hossam Elfeki, Veronica De Simone, Mostafa Shalaby, Celestino Gutierrez, Cihan Ozen, Ali Yalçınkaya, David Rivadeneira, Alssandro Sturiale, Nuha Yassin, Antonino Spinelli, Jay Warusavitarne, Argyrios Ioannidis, Steven Wexner, Julio Mayol. Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives. Crohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz021
|
| 28 |
Gabrielle Berger. The Perioperative Medicine Consult Handbook. 2015; doi: 10.1007/978-3-319-09366-6_17
|
| 29 |
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés, Fernando Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013). Gastroenterología y Hepatología 2013; 36(3) doi: 10.1016/j.gastrohep.2013.01.002
|
| 30 |
G Li, J Ren, G Wang, D Hu, G Gu, S Liu, H Ren, X Wu, J Li. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. European Journal of Clinical Nutrition 2014; 68(4) doi: 10.1038/ejcn.2014.16
|
| 31 |
Sandra M. Quezada, Leon P. McLean, Raymond K. Cross. Adverse events in IBD therapy: the 2018 update. Expert Review of Gastroenterology & Hepatology 2018; 12(12) doi: 10.1080/17474124.2018.1545574
|
| 32 |
S. R. Brown, N. S. Fearnhead, O. D. Faiz, J. F. Abercrombie, A. G. Acheson, R. G. Arnott, S. K. Clark, S. Clifford, R. J. Davies, M. M. Davies, W. J. P. Douie, M. G. Dunlop, J. C. Epstein, M. D. Evans, B. D. George, R. J. Guy, R. Hargest, A. B. Hawthorne, J. Hill, G. W. Hughes, J. K. Limdi, C. A. Maxwell‐Armstrong, P. R. O'Connell, T. D. Pinkney, J. Pipe, P. M. Sagar, B. Singh, M. Soop, H. Terry, J. Torkington, A. Verjee, C. J. Walsh, J. H. Warusavitarne, A. B. Williams, G. L. Williams, R. G. Wilson. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Disease 2018; 20(S8) doi: 10.1111/codi.14448
|